AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This will be a phase I/II clinical trial testing the combination of sorafenib and AZD6244 in
advanced hepatocellular carcinoma with Childs A liver cirrhosis. The aim of the phase I
portion is to determine appropriate dose of this drug combination. The phase 2 study will
look at effectiveness and safety of this drug combination